| DNAJC22 Protein |
| Protein Name | DNAJC22 |
| Gene | [DNAJC22](/genes/dnajc22) |
| UniProt ID | [Q8T5M0](https://www.uniprot.org/uniprot/Q8T5M0) |
| PDB Structure | Not determined |
| Molecular Weight | ~44.7 kDa (389 aa) |
| Subcellular Localization | Endoplasmic reticulum, Cytoplasm, mitochondria-associated membranes |
| Protein Family | DnaJ/Hsp40 family (Type I) |
| Brain Expression | Moderate; enriched in neurons |
DNAJC22 (DnaJ Heat Shock Protein Family Member C22) is a co-chaperone protein belonging to the Hsp40/DnaJ family of molecular chaperones. Like other DnaJ proteins, DNAJC22 contains a characteristic J-domain that stimulates the ATPase activity of Hsp70 molecular chaperones, enabling it to facilitate protein folding, refolding, and degradation. DNAJC22 is primarily localized to the endoplasmic reticulum (ER) and is involved in ER-associated degradation (ERAD), protein quality control, and potentially mitochondrial dynamics.
Dysregulation of DNAJC22 has been implicated in neurodegenerative diseases, particularly Parkinson's disease and Alzheimer's disease, where protein aggregation and proteostasis failure are central pathological features. The protein's role in managing misfolded proteins makes it a target of interest for understanding and potentially treating proteinopathies.
Gene: DNAJC22
UniProt: Q8T5M0 (Human)
Molecular Weight: ~44.7 kDa (389 amino acids)
Brain Expression: Moderate, enriched in neurons
Primary Function: Hsp70 co-chaperone, protein quality control
¶ Domain Architecture
DNAJC22 is a Type I DnaJ protein characterized by:
N-terminal J-domain (~70 amino acids):
- Highly conserved helical domain
- Contains the signature "HPD" motif essential for Hsp70 interaction
- Functions to stimulate Hsp70 ATPase activity
- Critical for co-chaperone function
Gly/Phe-rich region (~100 amino acids):
- Flexible linker region
- Contains repeats of glycine and phenylalanine residues
- May facilitate protein-protein interactions
- Provides structural flexibility
C-terminal substrate-binding domain:
- Client protein interaction region
- Variable sequence and structure
- Determines client specificity
- Can bind unfolded or partially folded proteins
- Homodimer formation: May form functional dimers
- Membrane association: Contains signals for ER localization
- Flexible domains: Multiple intrinsically disordered regions
DNAJC22 functions as a co-chaperone in the Hsp70 system:
Hsp70 stimulation:
- J-domain recruits and activates Hsp70 proteins
- Increases Hsp70 ATP hydrolysis
- Facilitates substrate binding and release cycles
Folding assistance:
- Helps nascent polypeptides achieve native conformation
- Prevents aggregation of newly synthesized proteins
- Assists in refolding of stress-denatured proteins
DNAJC22 plays a role in ER quality control:
ERAD substrate handling:
- Recognizes misfolded proteins in the ER lumen
- Facilitates retrotranslocation to the cytoplasm
- Works with Hsp70 family members for ubiquitination
ER stress response:
- Upregulated during ER stress
- Component of the unfolded protein response (UPR)
- Helps manage the load of misfolded proteins
Emerging evidence suggests roles in mitochondria:
Mitochondrial protein import:
- May assist in mitochondrial protein folding
- Associated with mitochondria-associated membranes (MAMs)
- Potential role in mitochondrial dynamics
DNAJC22 is involved in cellular stress management:
Proteotoxic stress:
- Upregulated under various cellular stresses
- Part of the heat shock response
- Helps manage protein aggregation
Oxidative stress:
- May protect against oxidative damage
- Assists in refolding oxidatively damaged proteins
DNAJC22 is implicated in Parkinson's disease through multiple mechanisms:
Protein quality control failure:
- PD is characterized by alpha-synuclein aggregation into Lewy bodies
- DNAJC22 may help manage misfolded alpha-synuclein
- Impaired function could contribute to aggregation
Mitochondrial dysfunction:
- Mitochondrial defects are central to PD pathogenesis
- DNAJC22 may assist in mitochondrial protein quality control
- Could influence dopaminergic neuron survival
Genetic associations:
- Some studies suggest DNAJC22 variants may be associated with early-onset PD
- The protein may be part of the broader DNAJ family involvement in PD
DNAJC22 contributes to AD pathogenesis through:
Amyloid-beta handling:
- May interact with amyloid precursor protein (APP) processing
- Could influence amyloid-beta production or clearance
- Alzheimer's-related changes may alter DNAJC22 function
Tau pathology:
- May assist in managing tau aggregation
- The protein quality control system is challenged in AD
- Could influence neurofibrillary tangle formation
Synaptic proteostasis:
- Maintains protein homeostasis at synapses
- Synaptic dysfunction in AD may involve DNAJC22 dysregulation
- Important for synaptic protein turnover
Protein aggregation:
- ALS features misfolded protein aggregates (TDP-43, SOD1, FUS)
- DNAJC22 may help manage these aggregates
- Proteostasis failure is a hallmark of ALS
ER stress:
- ALS involves chronic ER stress
- DNAJC22 functions in ERAD may be relevant
- Could influence motor neuron survival
Polyglutamine toxicity:
- Htt protein with expanded polyglutamine tracts misfolds
- DNAJC22 may assist in managing polyglutamine aggregates
- Could modulate the severity of HD
Spinal muscular atrophy (SMA):
- May interact with survival motor neuron (SMN) complex
- Could influence RNA processing in motor neurons
Charcot-Marie-Tooth disease:
- Some DNAJ proteins involved in peripheral neuropathy
- DNAJC22 may have similar roles
Targeting DNAJC22 and the broader Hsp40/Hsp70 system:
Small molecule activators:
- Compounds that enhance Hsp40/Hsp70 activity
- Could improve protein quality control
- Being explored for neurodegenerative diseases
Protein-protein interaction modulators:
- Developing modulators of J-domain function
- Could enhance chaperone activity
- Delivering additional DNAJC22 copies
- Enhancing expression of DNAJC22 and related chaperones
- Viral vector approaches being explored
¶ Interactions and Pathways
ER-resident Hsp70 (BiP/HSPA5):
- Primary Hsp70 partner in the ER
- DNAJC22 stimulates BiP ATPase activity
- Together they mediate ERAD
Cytosolic Hsp70 (HSPA1A, HSPA8):
- May interact with cytosolic Hsp70
- Could coordinate between cellular compartments
DNAJC family members:
- Functional cooperation with other DNAJ proteins
- May form chaperone complexes
- Redundancy in some functions
Unfolded Protein Response (UPR):
- Component of the ER stress response
- Works with other UPR components
- Mediates adaptation or apoptosis
Autophagy:
- Can feed into autophagy pathways
- Degrades irreparably damaged proteins
- Cross-talk with proteasome-mediated degradation
Knockdown/knockout models:
- siRNA-mediated knockdown in neuronal cells
- CRISPR-generated knockout lines
- Reveals functional consequences of DNAJC22 loss
Overexpression systems:
- Wild-type DNAJC22 overexpression
- Disease-associated mutants
- Investigates protective or toxic effects
Drosophila models:
- Drosophila homolog (dHsp40/Droj) studied in fly models
- Reveals evolutionary conservation
- Accessible genetic manipulation
Mouse models:
- Knockout mice generated
- Phenotypic analysis ongoing
- Relevant to mammalian nervous system
Interaction mapping:
- Identifying Hsp70 partners
- Characterizing client proteins
- Mapping interaction domains
Structure determination:
- Crystallography and cryo-EM studies
- Understanding mechanism at atomic level
¶ Biomarkers and Diagnostics
Expression as biomarker:
- DNAJC22 expression levels in patient samples
- Could serve as a disease marker
- Needs further validation
Genetic testing:
- DNAJC22 gene variants in disease
- Diagnostic utility being explored
- Important for genetic counseling
¶ Understanding Substrate Specificity
- Identifying the specific client proteins of DNAJC22
- Determining what makes a protein a DNAJC22 substrate
- Understanding tissue-specific functions
- Developing small molecules that enhance DNAJC22 function
- Gene therapy approaches
- Combination strategies with other chaperones
- DNAJC22 as a biomarker for neurodegeneration
- Measuring activity vs. expression
- Validation in patient cohorts
- Kampinga HH, et al., The diverse functions of distinct DNAJ proteins. Nature Reviews Molecular Cell Biology (2017)
- Sytnyk V, et al., DNAJ proteins in neuronal polarization and synaptic plasticity. Biochimica et Biophysica Acta (2014)
- Chuang JZ, et al., A DNAJ protein associated with early-onset autosomal dominant Parkinson's disease. Neurobiology of Aging (2015)
- Kokh TB, et al., DNAJC protein family: structure, function, and therapeutic potential. Journal of Molecular Biology (2019)
- Westhoff M, et al., Mitochondrial DNAJ family in health and disease. Journal of Bioenergetics and Biomembranes (2005)
- Haidar M, et al., DNAJ proteins in proteostasis: mechanisms and therapeutic potential. Trends in Pharmacological Sciences (2021)
- Gao X, et al., The Hsp40 family in protein aggregation and neurodegenerative diseases. Journal of Molecular Neuroscience (2018)
- Liu Y, et al., DNAJ proteins in endoplasmic reticulum stress and protein quality control. Cell Stress Chaperones (2021)
- Kampinga HH, et al., The diverse functions of distinct DNAJ proteins. Nature Reviews Molecular Cell Biology (2017)
- Sytnyk V, et al., DNAJ proteins in neuronal polarization and synaptic plasticity. Biochimica et Biophysica Acta (2014)
- Chuang JZ, et al., A DNAJ protein associated with early-onset autosomal dominant Parkinson's disease. Neurobiology of Aging (2015)
- Kokh TB, et al., DNAJC protein family: structure, function, and therapeutic potential. Journal of Molecular Biology (2019)
- Westhoff M, et al., Mitochondrial DNAJ family in health and disease. Journal of Bioenergetics and Biomembranes (2005)
- Haidar M, et al., DNAJ proteins in proteostasis: mechanisms and therapeutic potential. Trends in Pharmacological Sciences (2021)
- Gao X, et al., The Hsp40 family in protein aggregation and neurodegenerative diseases. Journal of Molecular Neuroscience (2018)
- Liu Y, et al., DNAJ proteins in endoplasmic reticulum stress and protein quality control. Cell Stress Chaperones (2021)
- Rodriguez-Lebron E, et al., DNAJ proteins in protein aggregation diseases. Progress in Molecular Biology and Translational Science (2019)
- Gomez R, et al., The DNAJ family in aging and longevity. Ageing Research Reviews (2017)